{"organizations": [], "uuid": "e8f26dcf903e0e9517c4a61b4f87cb9353320a3e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/2", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/05/08/pr-newswire-cphi-to-hold-first-quarter-2018-earnings-conference-call-on-tuesday-may-15-2018-at-830-a-m-et.html", "country": "US", "domain_rank": 767, "title": "CPHI to Hold First Quarter 2018 Earnings Conference Call On Tuesday May 15, 2018 at 8:30 a.m. ET", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.956, "site_type": "news", "published": "2018-05-08T16:00:00.000+03:00", "replies_count": 0, "uuid": "e8f26dcf903e0e9517c4a61b4f87cb9353320a3e"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/05/08/pr-newswire-cphi-to-hold-first-quarter-2018-earnings-conference-call-on-tuesday-may-15-2018-at-830-a-m-et.html", "ord_in_thread": 0, "title": "CPHI to Hold First Quarter 2018 Earnings Conference Call On Tuesday May 15, 2018 at 8:30 a.m. ET", "locations": [], "entities": {"persons": [], "locations": [{"name": "haikou", "sentiment": "none"}, {"name": "china", "sentiment": "none"}], "organizations": [{"name": "cphi", "sentiment": "negative"}, {"name": "china pharma holdings, inc.", "sentiment": "neutral"}, {"name": "company", "sentiment": "none"}, {"name": "cns", "sentiment": "none"}, {"name": "about china pharma holdings, inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "HAIKOU, China, China Pharma Holdings, Inc. (\"China Pharma\") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it plans to hold its first quarter 2018 earnings conference call on Tuesday, May 15, 2018 at 8:30 a.m. ET.\nListeners may access the call by dialing 1-866-519-4004 or 65-671-350-90 for international callers, Conference ID # 3765759 . A replay of the call will be accessible through May 23, 2018 by dialing 1-855-452-5696 or 61-281-990-299 for international callers, Conference ID # 3765759 .\nAbout China Pharma Holdings, Inc.\nChina Pharma Holdings, Inc. is a specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products focused on conditions with a high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective business model is driven by market demand and supported by new GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com . The Company routinely posts important information on its website.\nContact:\nChina Pharma Holdings, Inc.\nMs. Diana Na Huang\nPhone: +86-898-6681-1730 (China)\nEmail: hps@chinapharmaholdings.com\n : releases/cphi-to-hold-first-quarter-2018-earnings-conference-call-on-tuesday-may-15-2018-at-830-am-et-300644201.html\nSOURCE China Pharma Holdings, Inc.", "external_links": ["http://www.chinapharmaholdings.com/", "http://www.prnewswire.com/news-releases/cphi-to-hold-first-quarter-2018-earnings-conference-call-on-tuesday-may-15-2018-at-830-am-et-300644201.html"], "published": "2018-05-08T16:00:00.000+03:00", "crawled": "2018-05-08T16:50:28.008+03:00", "highlightTitle": ""}